Milrinone effects on cardiac mitochondria, hemodynamics, and death in catecholamine-infused rats
Background Catecholamine-storm is considered the major cause of enterovirus 71-associated cardiopulmonary death. To elucidate the effect of milrinone on cardiac mitochondria and death, a rat model of catecholamine-induced heart failure was investigated. Methods Young male Spray-Dawley rats received...
Gespeichert in:
Veröffentlicht in: | Pediatric research 2022-11, Vol.92 (5), p.1309-1315 |
---|---|
Hauptverfasser: | , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 1315 |
---|---|
container_issue | 5 |
container_start_page | 1309 |
container_title | Pediatric research |
container_volume | 92 |
creator | Lin, I-Chun Wu, Chih-Wei Lin, Ying-Jui Lo, Mao-Hung Hsieh, Kai-Sheng Chan, Julie Y. H. Wu, Kay L. H. |
description | Background
Catecholamine-storm is considered the major cause of enterovirus 71-associated cardiopulmonary death. To elucidate the effect of milrinone on cardiac mitochondria and death, a rat model of catecholamine-induced heart failure was investigated.
Methods
Young male Spray-Dawley rats received a continuous intravenous infusion of norepinephrine then followed by co-treatment with and without milrinone or esmolol. Vital signs were monitored and echocardiography was performed at indicated time points. At the end of experiments, hearts were extracted to study mitochondrial function, biogenesis, and DNA copy numbers.
Results
Hypernorepinephrinemia induced persistent tachycardia, hypertension, and high mortality and significantly impaired the activities of the electron transport chain and suppressed mitochondrial DNA copy number, mitochondrial transcription factor A and peroxisome proliferator-activated receptor-gamma coactivator 1-α. Norepinephrine-induced hypertension could be significantly suppressed by milrinone and esmolol. Milrinone improved but esmolol deteriorated the survival rate. The left ventricle was significantly enlarged shortly after norepinephrine infusion but later gradually reduced in size by milrinone. The impairment and suppression of mitochondrial function could be significantly reversed by milrinone but not by esmolol.
Conclusions
Milrinone may protect the heart via maintaining mitochondrial function from hypernorepinephrinemia. This study warrants the importance of milrinone and the preservation of mitochondrial function in the treatment of catecholamine-induced death.
Impact
Milrinone may protect the heart from hypernorepinephrinemia-induced death via maintaining myocardial mitochondrial activity, function, and copy number.
Maintenance of cardiac mitochondrial function may be a potential therapeutic strategy in such catecholamine-induced heart failure. |
doi_str_mv | 10.1038/s41390-022-01964-6 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8814569</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2740179581</sourcerecordid><originalsourceid>FETCH-LOGICAL-c474t-7a1c8fa03002d3d9d7ae8a7f65317590500b2630174fa1fa0c9b854192d792313</originalsourceid><addsrcrecordid>eNp9kU9PFTEUxRuikQf6BViYJmxYMHr7b9puSAgRNcG40XXtazu8kpkW2xkSvr19PgR04apJ7--cntuD0BGBdwSYel85YRo6oLQDonve9XtoRQRrV5zLF2gFwEjHtFb76KDWGwDCheKv0D4ThBIlYIV-fIljiSmngMMwBDdXnBN2tvhoHZ7inN0mJ1-iPcWbMGV_n-wUXT3FNnnsg503OG4Fc2jg2GYpdDENSw0eFzvX1-jlYMca3jych-j75YdvF5-6q68fP1-cX3WOSz530hKnBgsMgHrmtZc2KCuHXjAihQYBsKY9AyL5YEkDnV4rwYmmXmrKCDtEZzvf22U9Be9CmosdzW2Jky33Jtto_p6kuDHX-c4o1X6l183g5MGg5J9LqLOZYnVhHG0KeamG9rQHIpRUDT3-B73JS0ltPUMlbxm1UNtEdEe5kmstYXgMQ8BsCzS7Ak0r0Pwu0PRN9Pb5Go-SP401gO2A2kbpOpSnt_9j-wtU4KaX</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2740179581</pqid></control><display><type>article</type><title>Milrinone effects on cardiac mitochondria, hemodynamics, and death in catecholamine-infused rats</title><source>MEDLINE</source><source>SpringerLink Journals</source><source>EZB-FREE-00999 freely available EZB journals</source><source>Alma/SFX Local Collection</source><creator>Lin, I-Chun ; Wu, Chih-Wei ; Lin, Ying-Jui ; Lo, Mao-Hung ; Hsieh, Kai-Sheng ; Chan, Julie Y. H. ; Wu, Kay L. H.</creator><creatorcontrib>Lin, I-Chun ; Wu, Chih-Wei ; Lin, Ying-Jui ; Lo, Mao-Hung ; Hsieh, Kai-Sheng ; Chan, Julie Y. H. ; Wu, Kay L. H.</creatorcontrib><description>Background
Catecholamine-storm is considered the major cause of enterovirus 71-associated cardiopulmonary death. To elucidate the effect of milrinone on cardiac mitochondria and death, a rat model of catecholamine-induced heart failure was investigated.
Methods
Young male Spray-Dawley rats received a continuous intravenous infusion of norepinephrine then followed by co-treatment with and without milrinone or esmolol. Vital signs were monitored and echocardiography was performed at indicated time points. At the end of experiments, hearts were extracted to study mitochondrial function, biogenesis, and DNA copy numbers.
Results
Hypernorepinephrinemia induced persistent tachycardia, hypertension, and high mortality and significantly impaired the activities of the electron transport chain and suppressed mitochondrial DNA copy number, mitochondrial transcription factor A and peroxisome proliferator-activated receptor-gamma coactivator 1-α. Norepinephrine-induced hypertension could be significantly suppressed by milrinone and esmolol. Milrinone improved but esmolol deteriorated the survival rate. The left ventricle was significantly enlarged shortly after norepinephrine infusion but later gradually reduced in size by milrinone. The impairment and suppression of mitochondrial function could be significantly reversed by milrinone but not by esmolol.
Conclusions
Milrinone may protect the heart via maintaining mitochondrial function from hypernorepinephrinemia. This study warrants the importance of milrinone and the preservation of mitochondrial function in the treatment of catecholamine-induced death.
Impact
Milrinone may protect the heart from hypernorepinephrinemia-induced death via maintaining myocardial mitochondrial activity, function, and copy number.
Maintenance of cardiac mitochondrial function may be a potential therapeutic strategy in such catecholamine-induced heart failure.</description><identifier>ISSN: 0031-3998</identifier><identifier>EISSN: 1530-0447</identifier><identifier>DOI: 10.1038/s41390-022-01964-6</identifier><identifier>PMID: 35121850</identifier><language>eng</language><publisher>New York: Nature Publishing Group US</publisher><subject>Animals ; Basic Science ; Basic Science Article ; Cardiotonic Agents - pharmacology ; Catecholamines ; Heart failure ; Heart Failure - drug therapy ; Hemodynamics ; Hypertension ; Male ; Medicine ; Medicine & Public Health ; Milrinone - pharmacology ; Mitochondria, Heart ; Mitochondrial DNA ; Norepinephrine ; Pediatric Surgery ; Pediatrics ; Rats</subject><ispartof>Pediatric research, 2022-11, Vol.92 (5), p.1309-1315</ispartof><rights>The Author(s), under exclusive licence to the International Pediatric Research Foundation, Inc 2022</rights><rights>2022. The Author(s), under exclusive licence to the International Pediatric Research Foundation, Inc.</rights><rights>The Author(s), under exclusive licence to the International Pediatric Research Foundation, Inc 2022.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c474t-7a1c8fa03002d3d9d7ae8a7f65317590500b2630174fa1fa0c9b854192d792313</citedby><cites>FETCH-LOGICAL-c474t-7a1c8fa03002d3d9d7ae8a7f65317590500b2630174fa1fa0c9b854192d792313</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1038/s41390-022-01964-6$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1038/s41390-022-01964-6$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>230,314,776,780,881,27901,27902,41464,42533,51294</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/35121850$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Lin, I-Chun</creatorcontrib><creatorcontrib>Wu, Chih-Wei</creatorcontrib><creatorcontrib>Lin, Ying-Jui</creatorcontrib><creatorcontrib>Lo, Mao-Hung</creatorcontrib><creatorcontrib>Hsieh, Kai-Sheng</creatorcontrib><creatorcontrib>Chan, Julie Y. H.</creatorcontrib><creatorcontrib>Wu, Kay L. H.</creatorcontrib><title>Milrinone effects on cardiac mitochondria, hemodynamics, and death in catecholamine-infused rats</title><title>Pediatric research</title><addtitle>Pediatr Res</addtitle><addtitle>Pediatr Res</addtitle><description>Background
Catecholamine-storm is considered the major cause of enterovirus 71-associated cardiopulmonary death. To elucidate the effect of milrinone on cardiac mitochondria and death, a rat model of catecholamine-induced heart failure was investigated.
Methods
Young male Spray-Dawley rats received a continuous intravenous infusion of norepinephrine then followed by co-treatment with and without milrinone or esmolol. Vital signs were monitored and echocardiography was performed at indicated time points. At the end of experiments, hearts were extracted to study mitochondrial function, biogenesis, and DNA copy numbers.
Results
Hypernorepinephrinemia induced persistent tachycardia, hypertension, and high mortality and significantly impaired the activities of the electron transport chain and suppressed mitochondrial DNA copy number, mitochondrial transcription factor A and peroxisome proliferator-activated receptor-gamma coactivator 1-α. Norepinephrine-induced hypertension could be significantly suppressed by milrinone and esmolol. Milrinone improved but esmolol deteriorated the survival rate. The left ventricle was significantly enlarged shortly after norepinephrine infusion but later gradually reduced in size by milrinone. The impairment and suppression of mitochondrial function could be significantly reversed by milrinone but not by esmolol.
Conclusions
Milrinone may protect the heart via maintaining mitochondrial function from hypernorepinephrinemia. This study warrants the importance of milrinone and the preservation of mitochondrial function in the treatment of catecholamine-induced death.
Impact
Milrinone may protect the heart from hypernorepinephrinemia-induced death via maintaining myocardial mitochondrial activity, function, and copy number.
Maintenance of cardiac mitochondrial function may be a potential therapeutic strategy in such catecholamine-induced heart failure.</description><subject>Animals</subject><subject>Basic Science</subject><subject>Basic Science Article</subject><subject>Cardiotonic Agents - pharmacology</subject><subject>Catecholamines</subject><subject>Heart failure</subject><subject>Heart Failure - drug therapy</subject><subject>Hemodynamics</subject><subject>Hypertension</subject><subject>Male</subject><subject>Medicine</subject><subject>Medicine & Public Health</subject><subject>Milrinone - pharmacology</subject><subject>Mitochondria, Heart</subject><subject>Mitochondrial DNA</subject><subject>Norepinephrine</subject><subject>Pediatric Surgery</subject><subject>Pediatrics</subject><subject>Rats</subject><issn>0031-3998</issn><issn>1530-0447</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><recordid>eNp9kU9PFTEUxRuikQf6BViYJmxYMHr7b9puSAgRNcG40XXtazu8kpkW2xkSvr19PgR04apJ7--cntuD0BGBdwSYel85YRo6oLQDonve9XtoRQRrV5zLF2gFwEjHtFb76KDWGwDCheKv0D4ThBIlYIV-fIljiSmngMMwBDdXnBN2tvhoHZ7inN0mJ1-iPcWbMGV_n-wUXT3FNnnsg503OG4Fc2jg2GYpdDENSw0eFzvX1-jlYMca3jych-j75YdvF5-6q68fP1-cX3WOSz530hKnBgsMgHrmtZc2KCuHXjAihQYBsKY9AyL5YEkDnV4rwYmmXmrKCDtEZzvf22U9Be9CmosdzW2Jky33Jtto_p6kuDHX-c4o1X6l183g5MGg5J9LqLOZYnVhHG0KeamG9rQHIpRUDT3-B73JS0ltPUMlbxm1UNtEdEe5kmstYXgMQ8BsCzS7Ak0r0Pwu0PRN9Pb5Go-SP401gO2A2kbpOpSnt_9j-wtU4KaX</recordid><startdate>20221101</startdate><enddate>20221101</enddate><creator>Lin, I-Chun</creator><creator>Wu, Chih-Wei</creator><creator>Lin, Ying-Jui</creator><creator>Lo, Mao-Hung</creator><creator>Hsieh, Kai-Sheng</creator><creator>Chan, Julie Y. H.</creator><creator>Wu, Kay L. H.</creator><general>Nature Publishing Group US</general><general>Nature Publishing Group</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8C1</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20221101</creationdate><title>Milrinone effects on cardiac mitochondria, hemodynamics, and death in catecholamine-infused rats</title><author>Lin, I-Chun ; Wu, Chih-Wei ; Lin, Ying-Jui ; Lo, Mao-Hung ; Hsieh, Kai-Sheng ; Chan, Julie Y. H. ; Wu, Kay L. H.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c474t-7a1c8fa03002d3d9d7ae8a7f65317590500b2630174fa1fa0c9b854192d792313</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Animals</topic><topic>Basic Science</topic><topic>Basic Science Article</topic><topic>Cardiotonic Agents - pharmacology</topic><topic>Catecholamines</topic><topic>Heart failure</topic><topic>Heart Failure - drug therapy</topic><topic>Hemodynamics</topic><topic>Hypertension</topic><topic>Male</topic><topic>Medicine</topic><topic>Medicine & Public Health</topic><topic>Milrinone - pharmacology</topic><topic>Mitochondria, Heart</topic><topic>Mitochondrial DNA</topic><topic>Norepinephrine</topic><topic>Pediatric Surgery</topic><topic>Pediatrics</topic><topic>Rats</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Lin, I-Chun</creatorcontrib><creatorcontrib>Wu, Chih-Wei</creatorcontrib><creatorcontrib>Lin, Ying-Jui</creatorcontrib><creatorcontrib>Lo, Mao-Hung</creatorcontrib><creatorcontrib>Hsieh, Kai-Sheng</creatorcontrib><creatorcontrib>Chan, Julie Y. H.</creatorcontrib><creatorcontrib>Wu, Kay L. H.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Public Health Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Pediatric research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Lin, I-Chun</au><au>Wu, Chih-Wei</au><au>Lin, Ying-Jui</au><au>Lo, Mao-Hung</au><au>Hsieh, Kai-Sheng</au><au>Chan, Julie Y. H.</au><au>Wu, Kay L. H.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Milrinone effects on cardiac mitochondria, hemodynamics, and death in catecholamine-infused rats</atitle><jtitle>Pediatric research</jtitle><stitle>Pediatr Res</stitle><addtitle>Pediatr Res</addtitle><date>2022-11-01</date><risdate>2022</risdate><volume>92</volume><issue>5</issue><spage>1309</spage><epage>1315</epage><pages>1309-1315</pages><issn>0031-3998</issn><eissn>1530-0447</eissn><abstract>Background
Catecholamine-storm is considered the major cause of enterovirus 71-associated cardiopulmonary death. To elucidate the effect of milrinone on cardiac mitochondria and death, a rat model of catecholamine-induced heart failure was investigated.
Methods
Young male Spray-Dawley rats received a continuous intravenous infusion of norepinephrine then followed by co-treatment with and without milrinone or esmolol. Vital signs were monitored and echocardiography was performed at indicated time points. At the end of experiments, hearts were extracted to study mitochondrial function, biogenesis, and DNA copy numbers.
Results
Hypernorepinephrinemia induced persistent tachycardia, hypertension, and high mortality and significantly impaired the activities of the electron transport chain and suppressed mitochondrial DNA copy number, mitochondrial transcription factor A and peroxisome proliferator-activated receptor-gamma coactivator 1-α. Norepinephrine-induced hypertension could be significantly suppressed by milrinone and esmolol. Milrinone improved but esmolol deteriorated the survival rate. The left ventricle was significantly enlarged shortly after norepinephrine infusion but later gradually reduced in size by milrinone. The impairment and suppression of mitochondrial function could be significantly reversed by milrinone but not by esmolol.
Conclusions
Milrinone may protect the heart via maintaining mitochondrial function from hypernorepinephrinemia. This study warrants the importance of milrinone and the preservation of mitochondrial function in the treatment of catecholamine-induced death.
Impact
Milrinone may protect the heart from hypernorepinephrinemia-induced death via maintaining myocardial mitochondrial activity, function, and copy number.
Maintenance of cardiac mitochondrial function may be a potential therapeutic strategy in such catecholamine-induced heart failure.</abstract><cop>New York</cop><pub>Nature Publishing Group US</pub><pmid>35121850</pmid><doi>10.1038/s41390-022-01964-6</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0031-3998 |
ispartof | Pediatric research, 2022-11, Vol.92 (5), p.1309-1315 |
issn | 0031-3998 1530-0447 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8814569 |
source | MEDLINE; SpringerLink Journals; EZB-FREE-00999 freely available EZB journals; Alma/SFX Local Collection |
subjects | Animals Basic Science Basic Science Article Cardiotonic Agents - pharmacology Catecholamines Heart failure Heart Failure - drug therapy Hemodynamics Hypertension Male Medicine Medicine & Public Health Milrinone - pharmacology Mitochondria, Heart Mitochondrial DNA Norepinephrine Pediatric Surgery Pediatrics Rats |
title | Milrinone effects on cardiac mitochondria, hemodynamics, and death in catecholamine-infused rats |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-10T08%3A06%3A39IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Milrinone%20effects%20on%20cardiac%20mitochondria,%20hemodynamics,%20and%20death%20in%20catecholamine-infused%20rats&rft.jtitle=Pediatric%20research&rft.au=Lin,%20I-Chun&rft.date=2022-11-01&rft.volume=92&rft.issue=5&rft.spage=1309&rft.epage=1315&rft.pages=1309-1315&rft.issn=0031-3998&rft.eissn=1530-0447&rft_id=info:doi/10.1038/s41390-022-01964-6&rft_dat=%3Cproquest_pubme%3E2740179581%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2740179581&rft_id=info:pmid/35121850&rfr_iscdi=true |